BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 23, 2001
View Archived Issues
Pravastatin highlighted at ACC scientific sessions
Read More
Welfide and Mitsubishi-Tokyo Pharmaceuticals to merge
Read More
FDA requests additional information to support Bexxar BLA
Read More
Leiras and Nycomed Pharma create joint venture
Read More
Ligand updates Targretin development programs in NSCLC, breast cancer and psoriasis
Read More
BNP levels reliably detect LV dysfunction in diabetics
Read More
MediGene's NV-1020 shows good safety profile in phase I
Read More
Experiments in human arteries suggest potential of SLV-306 in CHD
Read More
Medco's new stress imaging agent induces coronary hyperemia with few adverse effects
Read More
AstraZeneca's Nexium for erosive esophagitis launched in U.S.
Read More
L-Arginine has beneficial effects in a range of cardiovascular disorders
Read More
Roche seeks FDA approval for Xenical as adjunct in type 2 diabetes
Read More
First well-controlled trial of cardiovascular gene therapy discussed at late-breaking ACC session
Read More
Novel NK2 antagonist effective in guinea pig models of asthma symptoms
Read More
KAD-1229 more effective than nateglinide or voglibose against postprandial hyperglycemia
Read More
Calyx commences phase II trial of CLX-0901 in type 2 diabetes
Read More
OPC-51803, a new vasopressin V2 agonist, characterized in dogs
Read More
Development of Immunex's Enbrel for CHF halted
Read More
Versicor begins phase III trial with V-echinocandin for treatment of esophageal candidiasis
Read More
ACC news: halofuginone reduces neointimal hyperplasia in response to coronary stenting in pigs
Read More
Multiple-cytokine fusion proteins prepared at Lexigen for use in cancer
Read More
Anxiolytic isoquinolines disclosed by Egis researchers
Read More
Two patents issued to Novuspharma cover new antitumor agents
Read More
Biochemie presents new antibacterial mutilin derivatives
Read More
Cyclic and acyclic amine derivatives under study at Vertex for use in neurological disorders
Read More
Aventis antitumor agents act by inhibiting Ras farnesylation
Read More
Hungarian scientists claim new series of heterocyclic angiogenesis inhibitors
Read More
Neuropeptide Y receptor antagonists designed at Ortho-McNeil
Read More
Morphochem and Aventis to develop novel diabetes treatment
Read More